We are live on
!
Find out more
DMKJ
David M. Knott Jr Portfolio holdings
AUM
$168M
1-Year Est. Return
60.36%
This Fund
S&P 500
This Quarter
Est. Return
+12.82%
1 Year Est. Return
+60.36%
3 Year Est. Return
+143.93%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$221M
AUM Growth
+$8.65M
(+4.1%)
Cap. Flow
-$6.33M
Cap. Flow
% of AUM
-2.87%
Top 10 Holdings %
Top 10 Hldgs %
71.57%
Holding
93
New
9
Increased
15
Reduced
13
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BridgeBio Pharma
BBIO
|
+$2.91M |
| 2 |
Syndax Pharmaceuticals
SNDX
|
+$2.47M |
| 3 |
LENZ
LENZ Therapeutics
LENZ
|
+$2.23M |
| 4 |
Alkermes
ALKS
|
+$1.46M |
| 5 |
Liquidia Corp
LQDA
|
+$1.33M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$4.2M |
| 2 |
Janus Henderson AAA CLO ETF
JAAA
|
+$2.85M |
| 3 |
VRNA
Verona Pharma
VRNA
|
+$2.44M |
| 4 |
Ardelyx
ARDX
|
+$2.42M |
| 5 |
OmniAb
OABI
|
+$2.36M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.49% |
| 2 | Materials | 24.07% |
| 3 | Financials | 19.36% |
| 4 | Communication Services | 9.05% |
| 5 | Industrials | 1.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Blackstone
BX
$104B
| $31.4K | 0.01% |
210
| – | – |
|
77
Occidental Petroleum
OXY
$57B
| $24K | 0.01% |
663
| – | – |
|
78
Salesforce
CRM
$134B
| $21K | 0.01% |
77
| – | – |
|
79
Thermo Fisher Scientific
TMO
$211B
| $18.2K | 0.01% |
45
| – | – |
|
80
Kyndryl
KD
$2.66B
| $18K | 0.01% |
428
| – | – |
|
81
UnitedHealth
UNH
$382B
| $17.8K | 0.01% |
57
| – | – |
|
82
Starwood Property Trust
STWD
$6.12B
| $8.03K | ﹤0.01% |
400
| – | – |
|
83
GE HealthCare
GEHC
$27.6B
| $3.7K | ﹤0.01% |
50
| – | – |
|
84
Wabtec
WAB
$51.1B
| $1.26K | ﹤0.01% |
6
| – | – |
|
|
85
Ardelyx
ARDX
$1.24B
| – | – |
-493,807
| Closed | -$2.42M |
|
86
Panagram AAA CLO ETF
CLOX
$310M
| – | – |
-5,766
| Closed | -$147K |
|
87
Cogent Biosciences
COGT
$6.79B
| – | – |
-213,302
| Closed | -$1.28M |
|
88
Invesco AAA CLO Floating Rate Note ETF
ICLO
$510M
| – | – |
-70,502
| Closed | -$1.8M |
|
89
Immunovant
IMVT
$8.09B
| – | – |
-22,443
| Closed | -$384K |
|
90
MeiraGTx Holdings
MGTX
$1.09B
| – | – |
-125,010
| Closed | -$848K |
|
|
91
OmniAb
OABI
$294M
| – | – |
-982,336
| Closed | -$2.36M |
|
92
Regeneron Pharmaceuticals
REGN
$68.8B
| – | – |
-2,000
| Closed | -$1.27M |
|
Similar funds
DI
WFS
CCG
7CM
MAG
PFA
CW
IWA
David M. Knott Jr's Q2 2025 Portfolio in Review
As of Q2 2025, David M. Knott Jr held 93 positions worth $221M, up 4.1% from $212M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
David M. Knott Jr's Q2 2025 filing shows 9 new, 15 increased, 13 reduced and 8 closed positions. Its largest new stake was BridgeBio Pharma: 80,000 shares worth $3.45M. The largest sale was Pfizer, an estimated $4.2M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Materials and Financials.
- David M. Knott Jr's largest Q2 2025 buy was BridgeBio Pharma: 80,000 shares worth $3.45M.
- David M. Knott Jr added most to Syndax Pharmaceuticals in Q2 2025, an estimated $2.47M increase.
- David M. Knott Jr's biggest Q2 2025 reduction was Pfizer, cutting an estimated $4.2M.
- David M. Knott Jr fully exited Ardelyx in Q2 2025, selling an estimated $2.42M.
- David M. Knott Jr's ten largest holdings make up 72% of its $221M portfolio in Q2 2025.
- David M. Knott Jr opened 9 new positions and closed 8 in Q2 2025.
- David M. Knott Jr's portfolio value rose 4.1% quarter-over-quarter to $221M.
Based on David M. Knott Jr's 13F filing for Q2 2025, filed 11 Aug 2025.